← Back to Patent Explorer
US4183914A Expired / Lapsed US ⏱️ 0.0 years remaining

Magnesium polycarboxylate complexes and anticalculus agents

Assignee: Individual
•
Filing: 1977-12-19
•
Granted: 1980-01-15
•
Expires: 1997-12-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel composition to prevent and control dental calculus containing as the essential agent, a magnesium polycarboxylate complex formed by the reaction or interaction of a magnesium compound with a polycarboxylate selected from the group consisting of maleic acid copolymers, sulfoacrylic acid oligomers, and tricarboxy-oxa-butanol or pentanol.

Inventors

  • 👤 Abdul Gaffar
  • 👤 Maria C. S. Gaffar

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 02:57
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/19; A61K8/72; A61K8/81; A61K8/8164; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0056; A61K9/0058; A61Q; A61Q11/00; A61K2800/00; A61K2800/40; A61K2800/58

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 115 words
An oral composition comprising a dental cream, mouthrinse, troche or lozenge, chewing gum, dental tablet or powder or mouthspray containing as the essential anticalculus agent, a magnesium polycarboxylate complex of a magnesium compound and a polycarboxylate compound in the ratio of 1:40 to about 4:1 magnesium compound to polycarboxylate and having a pH of about 4.5-7.8, wherein said polycarboxylate contains ionizable carboxyl groups and is a copolymer of maleic acid or anhydride and of an olefin having 2 or more carbon atoms per molecule, and is ionically bound to a dissociable, physiologically acceptable magnesium compound, wherein said magnesium compound constitutes about 0.01-5% by weight and the polycarboxylate constitutes about 0.1-10% by weight of the composition.
Claim 2
Dependent Claim 115 words
An oral composition comprising a dental cream, mouthrinse, troche or lozenge, chewing gum, dental tablet or powder or mouthspray containing as the essential anticalculus agent, a magnesium polycarboxylate complex of a magnesium compound and a polycarboxylate compound in the ratio of 1:40 to about 4:1 magnesium compound to polycarboxylate and having a pH of about 4.5-7.8, wherein said polycarboxylate contains ionizable carboxyl groups and is a copolymer of maleic acid or anhydride and of an olefin having 2 or more carbon atoms per molecule, and is ionically bound to a dissociable, physiologically acceptable magnesium compound, wherein said magnesium compound constitutes about 0.01-5% by weight and the polycarboxylate constitutes about 0.1-10% by weight of the composition.
Claim 3
Dependent Claim 56 words
A composition in accordance with claim 1, wherein the copolymer of maleic acid or anhydride has recurring groups: ##STR10## wherein M and M 1 are individually hydrogen, sodium, potassium or ammonium and may be the same or different, and X is selected from the group consisting of ethylene, styrene, isobutylene, methylvinyl ether, and ethyl vinyl ether.
Claim 4
Dependent Claim 19 words
A composition in accordance with claim 2, wherein said polycarboxylate is a copolymer of maleic anhydride and methylvinyl ether.
Claim 5
Dependent Claim 14 words
A composition in accordance with claim 1, wherein said magnesium compound is magnesium oxide.
Claim 6
Dependent Claim 14 words
A composition in accordance with claim 1, wherein said magnesium compound in magnesium chloride.
Claim 7
Dependent Claim 43 words
A method of preventing and controlling dental calculus which comprises applying the composition of claim 1 to the oral cavity, wherein the magnesium polycarboxylate complex adsorbs onto the oral surfaces forming a reservoir of magnesium ions which is slowly released within said cavity.
Claim 8
Dependent Claim 17 words
A method in accordance with claim 6 which comprises washing the oral cavity with an aqueous mouthrinse.
Claim 9
Dependent Claim 16 words
A method in accordance with claim 6 which comprises brushing the teeth with a dental cream.

References Cited (Backward Citations)

US1817664A Cited
US3429963A Cited
US3452049A Cited
US3558769A Cited
US3689636A Cited
DE2164383A1 Cited
US4058595A Cited
US3991177A Cited
US3956480A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-01-14 1983-07-16 1984-01-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-01-14 1987-07-16 1988-01-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-01-14 1991-07-16 1992-01-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag